Lufenuron treatment temporarily represses gene expression and affects the SUMO pathway in liver of Atlantic salmon

© 2023 The Authors. Journal of Fish Diseases published by John Wiley & Sons Ltd.

Bibliographische Detailangaben
Veröffentlicht in:Journal of fish diseases. - 1998. - 47(2024), 2 vom: 02. Feb., Seite e13880
1. Verfasser: Olsvik, Pål A (VerfasserIn)
Weitere Verfasser: Brokke, Kristine E, Samuelsen, Ole B, Hannisdal, Rita
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Journal of fish diseases
Schlagworte:Journal Article Atlantic salmon liver tissue RNA-seq bioaccumulation lufenuron pathway analysis salmon lice drugs fluphenacur 1R754M4918
LEADER 01000caa a22002652c 4500
001 NLM36424996X
003 DE-627
005 20250305102423.0
007 cr uuu---uuuuu
008 231226s2024 xx |||||o 00| ||eng c
024 7 |a 10.1111/jfd.13880  |2 doi 
028 5 2 |a pubmed25n1213.xml 
035 |a (DE-627)NLM36424996X 
035 |a (NLM)37933190 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Olsvik, Pål A  |e verfasserin  |4 aut 
245 1 0 |a Lufenuron treatment temporarily represses gene expression and affects the SUMO pathway in liver of Atlantic salmon 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 11.01.2024 
500 |a Date Revised 16.01.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2023 The Authors. Journal of Fish Diseases published by John Wiley & Sons Ltd. 
520 |a Lufenuron is a benzoylurea insecticide currently in use to combat sea lice infestation in salmon aquaculture in Chile. With pending approval in Norway, the aim of this work was to study the uptake and toxicity of lufenuron in liver tissue of Atlantic salmon. Juvenile salmon weighing 40 g were given a standard 7-day oral dose, and bioaccumulation and transcriptional responses in the liver were examined 1 day after the end-of-treatment (day 8) and after 1 week of elimination (day 14). Bioaccumulation levels of lufenuron were 29 ± 3 mg/kg at day 8 and 14 ± 1 mg/kg at day 14, indicating relatively rapid clearance. However, residues of lufenuron were still present in the liver after 513 days of depuration. The exposure gave a transient inhibition of transcription in the liver at day 8 (2437 significant DEGs, p-adj < .05), followed by a weaker compensatory response at day 14 (169 significant DEGs). Pathways associated with RNA metabolism such as the sumoylation pathway were most strongly affected at day 8, while the apelin pathway was most profoundly affected at day 14. In conclusion, this study shows that lufenuron easily bioaccumulates and that a standard 7-day oral dose induces a transient inhibition of transcription in liver of salmon 
650 4 |a Journal Article 
650 4 |a Atlantic salmon liver tissue 
650 4 |a RNA-seq 
650 4 |a bioaccumulation 
650 4 |a lufenuron 
650 4 |a pathway analysis 
650 4 |a salmon lice drugs 
650 7 |a fluphenacur  |2 NLM 
650 7 |a 1R754M4918  |2 NLM 
700 1 |a Brokke, Kristine E  |e verfasserin  |4 aut 
700 1 |a Samuelsen, Ole B  |e verfasserin  |4 aut 
700 1 |a Hannisdal, Rita  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Journal of fish diseases  |d 1998  |g 47(2024), 2 vom: 02. Feb., Seite e13880  |w (DE-627)NLM098166034  |x 1365-2761  |7 nnas 
773 1 8 |g volume:47  |g year:2024  |g number:2  |g day:02  |g month:02  |g pages:e13880 
856 4 0 |u http://dx.doi.org/10.1111/jfd.13880  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 47  |j 2024  |e 2  |b 02  |c 02  |h e13880